Curis, Inc.

NasdaqCM:CRIS Stock Report

Market Cap: US$27.7m

Curis Future Growth

Future criteria checks 2/6

Curis is forecast to grow earnings and revenue by 8.1% and 43.9% per annum respectively while EPS is expected to grow by 40.6% per annum.

Key information

8.1%

Earnings growth rate

40.6%

EPS growth rate

Biotechs earnings growth27.2%
Revenue growth rate43.9%
Future return on equityn/a
Analyst coverage

Good

Last updated11 Dec 2024

Recent future growth updates

Recent updates

Curis, Inc.'s (NASDAQ:CRIS) 26% Dip In Price Shows Sentiment Is Matching Revenues

Dec 29
Curis, Inc.'s (NASDAQ:CRIS) 26% Dip In Price Shows Sentiment Is Matching Revenues

Curis, Inc.'s (NASDAQ:CRIS) 26% Dip In Price Shows Sentiment Is Matching Revenues

Nov 14
Curis, Inc.'s (NASDAQ:CRIS) 26% Dip In Price Shows Sentiment Is Matching Revenues

Growth Investors: Industry Analysts Just Upgraded Their Curis, Inc. (NASDAQ:CRIS) Revenue Forecasts By 15%

Aug 07
Growth Investors: Industry Analysts Just Upgraded Their Curis, Inc. (NASDAQ:CRIS) Revenue Forecasts By 15%

Improved Revenues Required Before Curis, Inc. (NASDAQ:CRIS) Shares Find Their Feet

Aug 05
Improved Revenues Required Before Curis, Inc. (NASDAQ:CRIS) Shares Find Their Feet

Curis, Inc. (NASDAQ:CRIS) Surges 27% Yet Its Low P/S Is No Reason For Excitement

Apr 03
Curis, Inc. (NASDAQ:CRIS) Surges 27% Yet Its Low P/S Is No Reason For Excitement

Curis, Inc. (NASDAQ:CRIS) Stock Catapults 63% Though Its Price And Business Still Lag The Industry

Dec 26
Curis, Inc. (NASDAQ:CRIS) Stock Catapults 63% Though Its Price And Business Still Lag The Industry

We're A Little Worried About Curis' (NASDAQ:CRIS) Cash Burn Rate

Nov 03
We're A Little Worried About Curis' (NASDAQ:CRIS) Cash Burn Rate

We're Hopeful That Curis (NASDAQ:CRIS) Will Use Its Cash Wisely

Aug 05
We're Hopeful That Curis (NASDAQ:CRIS) Will Use Its Cash Wisely

Will Curis (NASDAQ:CRIS) Spend Its Cash Wisely?

Apr 19
Will Curis (NASDAQ:CRIS) Spend Its Cash Wisely?

Is Curis (NASDAQ:CRIS) In A Good Position To Invest In Growth?

Jan 02
Is Curis (NASDAQ:CRIS) In A Good Position To Invest In Growth?

Will Curis (NASDAQ:CRIS) Spend Its Cash Wisely?

Sep 16
Will Curis (NASDAQ:CRIS) Spend Its Cash Wisely?

Curis stock soars 34% as FDA lifts partial clinical hold on emavusertib's lymphoma study

Aug 18

Curis: Asymmetric Risk And Reward

Jul 17

Here's Why We're Not Too Worried About Curis' (NASDAQ:CRIS) Cash Burn Situation

Mar 28
Here's Why We're Not Too Worried About Curis' (NASDAQ:CRIS) Cash Burn Situation

Checking In On Curis

Dec 15

Companies Like Curis (NASDAQ:CRIS) Can Afford To Invest In Growth

Dec 04
Companies Like Curis (NASDAQ:CRIS) Can Afford To Invest In Growth

Earnings and Revenue Growth Forecasts

NasdaqCM:CRIS - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202726-51-41-774
12/31/202611-53-61-476
12/31/20259-45-12-386
12/31/202410-45-15-395
9/30/202410-45-40-40N/A
6/30/202410-48-43-43N/A
3/31/202410-48-39-39N/A
12/31/202310-47-38-38N/A
9/30/202310-47-41-41N/A
6/30/202310-48-46-45N/A
3/31/202310-52-50-50N/A
12/31/202210-57-55-54N/A
9/30/202210-59-51-50N/A
6/30/202211-57-47-47N/A
3/31/202211-52-41-41N/A
12/31/202111-45-38-38N/A
9/30/202111-39-35-35N/A
6/30/202110-34-32-31N/A
3/31/202110-30-30-30N/A
12/31/202011-30-26-26N/A
9/30/202011-31-26-26N/A
6/30/202011-31-27-26N/A
3/31/202011-32-28-28N/A
12/31/201910-32-26-26N/A
9/30/20199-29-26-26N/A
6/30/20199-30-27-27N/A
3/31/201910-32-27-27N/A
12/31/201810-33-30-30N/A
9/30/201811-35-33-33N/A
6/30/201811-43N/A-41N/A
3/31/201810-48N/A-43N/A
12/31/201710-53N/A-48N/A
9/30/20179-57N/A-50N/A
6/30/20178-70N/A-41N/A
3/31/20178-67N/A-43N/A
12/31/20168-60N/A-36N/A
9/30/20167-63N/A-37N/A
6/30/20168-40N/A-34N/A
3/31/20168-37N/A-30N/A
12/31/20158-59N/A-30N/A
9/30/20158-51N/A-24N/A
6/30/20157-51N/A-21N/A
3/31/201510-45N/A-19N/A
12/31/201410-19N/A-17N/A
9/30/20149-17N/A-18N/A
6/30/201415-14N/A-15N/A
3/31/201415-13N/A-11N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CRIS is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: CRIS is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: CRIS is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: CRIS's revenue (43.9% per year) is forecast to grow faster than the US market (9% per year).

High Growth Revenue: CRIS's revenue (43.9% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if CRIS's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/23 22:47
End of Day Share Price 2025/01/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Curis, Inc. is covered by 26 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Brian SkorneyBaird
James BirchenoughBMO Capital Markets Equity Research
Brian SkorneyBrean Capital